Literature DB >> 7498547

cDNA sequences of three sheep myeloid cathelicidins.

L Bagella1, M Scocchi, M Zanetti.   

Abstract

Several myeloid antimicrobial peptide precursors have been shown to consist of a N-terminal proregion similar to a protein named cathelin and a structurally varied C-terminal antimicrobial domain. Proteins with these features have been named cathelicidins. In this paper we report the cDNA sequences of three ovine cathelicidins of 155, 160 and 190 residues, respectively, with cationic C-terminal sequences corresponding to putative antimicrobial domains. These are structurally varied and include a Cys-rich sequence of 12 residues, which is similar to the bovine antimicrobial cyclic dodecapeptide, a novel 29 residue sequence named SMAP-29 with a possible alpha-helical conformation, and a 60 residue sequence named Bac7.5, which appears to be a new member of the Pro- and Arg-rich group of mammalian antimicrobial peptides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498547     DOI: 10.1016/0014-5793(95)01285-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.

Authors:  V C Kalfa; H P Jia; R A Kunkle; P B McCray; B F Tack; K A Brogden
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 2.  Antimicrobial peptide killing of African trypanosomes.

Authors:  J M Harrington
Journal:  Parasite Immunol       Date:  2011-08       Impact factor: 2.280

3.  Antimicrobial activity and bacterial-membrane interaction of ovine-derived cathelicidins.

Authors:  Rachel C Anderson; Robert E W Hancock; Pak-Lam Yu
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

Review 4.  Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?

Authors:  Nicole K Brogden; Kim A Brogden
Journal:  Int J Antimicrob Agents       Date:  2011-07-05       Impact factor: 5.283

5.  Activity of protegrins against yeast-phase Candida albicans.

Authors:  Y Cho; J S Turner; N N Dinh; R I Lehrer
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Effects of pH and salinity on the antimicrobial properties of clavanins.

Authors:  I H Lee; Y Cho; R I Lehrer
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.

Authors:  L Saiman; S Tabibi; T D Starner; P San Gabriel; P L Winokur; H P Jia; P B McCray; B F Tack
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

8.  RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey.

Authors:  C Zhao; T Nguyen; L M Boo; T Hong; C Espiritu; D Orlov; W Wang; A Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

9.  Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

Authors:  Lars Steinstraesser; Brian F Tack; Alan J Waring; Teresa Hong; Lee M Boo; Ming-Hui Fan; Daniel I Remick; Grace L Su; Robert I Lehrer; Stewart C Wang
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

10.  Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.

Authors:  Z Oren; J C Lerman; G H Gudmundsson; B Agerberth; Y Shai
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.